EP 4146690 A1 20230315 - ANTIBODIES AGAINST SARS-COV-2
Title (en)
ANTIBODIES AGAINST SARS-COV-2
Title (de)
ANTIKÖRPER GEGEN SARS-COV-2
Title (fr)
ANTICORPS CONTRE SARS-COV-2
Publication
Application
Priority
- US 202063022392 P 20200508
- US 202063024372 P 20200513
- US 202063027814 P 20200520
- US 202063029338 P 20200522
- US 202063031286 P 20200528
- US 202063033045 P 20200601
- US 202063036683 P 20200609
- US 202063039939 P 20200616
- US 202063046465 P 20200630
- US 202063057767 P 20200728
- US 202063090667 P 20201012
- US 202063113450 P 20201113
- US 202163153784 P 20210225
- US 202163170368 P 20210402
- US 2021031442 W 20210507
Abstract (en)
[origin: WO2021226560A1] The instant disclosure provides antibodies and antigen-binding fragments thereof that can bind to a SARS-CoV-2 antigen and, in certain embodiments, are capable of potently neutralizing a SARS-CoV-2 infection. Also provided are polynucleotides that encode antibodies and antigen-binding fragments, vectors, host cells, and related compositions and uses, including for preventing, treating, and diagnosing an infection by SARS-CoV-2 or another coronavirus.
IPC 8 full level
C07K 16/10 (2006.01); A61K 39/395 (2006.01); A61P 31/14 (2006.01)
CPC (source: EP IL KR)
A61P 31/14 (2018.01 - EP IL KR); C07K 16/10 (2013.01 - IL KR); C07K 16/1003 (2023.08 - EP); A61K 2039/505 (2013.01 - EP IL KR); A61K 2039/507 (2013.01 - EP IL); C07K 2317/21 (2013.01 - EP IL); C07K 2317/24 (2013.01 - KR); C07K 2317/31 (2013.01 - KR); C07K 2317/41 (2013.01 - KR); C07K 2317/55 (2013.01 - KR); C07K 2317/622 (2013.01 - KR); C07K 2317/72 (2013.01 - KR); C07K 2317/76 (2013.01 - EP IL KR); C07K 2317/92 (2013.01 - EP IL KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021226560 A1 20211111; AU 2021268361 A1 20221208; BR 112022022523 A2 20230110; CA 3177169 A1 20211111; CL 2022003085 A1 20230901; CO 2022017670 A2 20230307; EP 4146690 A1 20230315; IL 297988 A 20230101; JP 2023525039 A 20230614; KR 20230010676 A 20230119; MX 2022013886 A 20221130
DOCDB simple family (application)
US 2021031442 W 20210507; AU 2021268361 A 20210507; BR 112022022523 A 20210507; CA 3177169 A 20210507; CL 2022003085 A 20221107; CO 2022017670 A 20221206; EP 21729694 A 20210507; IL 29798822 A 20221106; JP 2022567512 A 20210507; KR 20227043022 A 20210507; MX 2022013886 A 20210507